GridAI Technologies (GRDX) Long-Term Debt Repayments (2019 - 2020)
GridAI Technologies' (GRDX) quarterly Long-Term Debt Repayments came in at $25000.0 in Q3 2020, down 94.44% quarter-over-quarter from $450000.0 in Q1 2020.
Powered by 
Analysis
GridAI Technologies (GRDX) Long-Term Debt Repayments (2019 - 2020) Analysis & Trends
GridAI Technologies (GRDX) has reported Long-Term Debt Repayments for 2 consecutive years, with $25000.0 the latest figure, recorded in Q3 2020.
- For the quarter ending Q3 2020, Long-Term Debt Repayments changed N/A year-over-year to $25000.0; the trailing twelve-month figure through Jun 2021 stood at $25000.0 (down 98.75% YoY), and the FY2020 full-year result was $475000.0, down 69.35% from the prior year.
- Long-Term Debt Repayments declined to $25000.0 in Q3 2020 per GRDX's latest filing, from $450000.0 in the prior quarter.
- Across five years, Long-Term Debt Repayments topped out at $1.5 million in Q4 2019 and bottomed at $25000.0 in Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | - |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 25,000.00 |
| Mar 31, 2020 | 450,000.00 |
| Dec 31, 2019 | 1.55 Mn |